JP2013544840A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544840A5 JP2013544840A5 JP2013542121A JP2013542121A JP2013544840A5 JP 2013544840 A5 JP2013544840 A5 JP 2013544840A5 JP 2013542121 A JP2013542121 A JP 2013542121A JP 2013542121 A JP2013542121 A JP 2013542121A JP 2013544840 A5 JP2013544840 A5 JP 2013544840A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- alkyl
- pyridinyl
- oxo
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 amino, hydroxy Chemical group 0.000 claims 67
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 43
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 33
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 33
- 125000001072 heteroaryl group Chemical group 0.000 claims 33
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 29
- 125000003118 aryl group Chemical group 0.000 claims 25
- 229910052739 hydrogen Inorganic materials 0.000 claims 25
- 125000005843 halogen group Chemical group 0.000 claims 23
- 239000001257 hydrogen Substances 0.000 claims 22
- 125000004093 cyano group Chemical group *C#N 0.000 claims 21
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 claims 19
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 19
- 229910052757 nitrogen Inorganic materials 0.000 claims 15
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- 229910052760 oxygen Inorganic materials 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 10
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 10
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 10
- 150000001602 bicycloalkyls Chemical group 0.000 claims 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 10
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 9
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 7
- 125000003282 alkyl amino group Chemical group 0.000 claims 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 229910052717 sulfur Chemical group 0.000 claims 5
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 claims 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 4
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 4
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229910002091 carbon monoxide Inorganic materials 0.000 claims 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 4
- 125000005312 heteroarylalkynyl group Chemical group 0.000 claims 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims 4
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims 2
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 claims 2
- LCDDIHUXAJMESP-UHFFFAOYSA-N 1-methyl-n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-5-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3N(C)C=C(C=3C=C(C=2)C=2C=NC(=CC=2)N2CCN(C)CC2)C(C)C)=C1CCC LCDDIHUXAJMESP-UHFFFAOYSA-N 0.000 claims 2
- LXLLQCXEEJYPGG-UHFFFAOYSA-N 5-(2-aminopyrimidin-5-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CN=C(N)N=C1 LXLLQCXEEJYPGG-UHFFFAOYSA-N 0.000 claims 2
- WBXZCPSJRRPXBO-UHFFFAOYSA-N 5-(6-aminopyridin-3-yl)-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(N)N=C1 WBXZCPSJRRPXBO-UHFFFAOYSA-N 0.000 claims 2
- ZVHJZHRMJQXLQC-UHFFFAOYSA-N 5-[3-[(dimethylamino)methyl]phenyl]-1-methyl-n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3N(C)C=C(C=3C=C(C=2)C=2C=C(CN(C)C)C=CC=2)C(C)C)=C1CCC ZVHJZHRMJQXLQC-UHFFFAOYSA-N 0.000 claims 2
- ICIARSXAAGBILQ-UHFFFAOYSA-N 5-[3-[(dimethylamino)methyl]phenyl]-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=CC(CN(C)C)=C1 ICIARSXAAGBILQ-UHFFFAOYSA-N 0.000 claims 2
- GFCCWLHFGVSSSS-UHFFFAOYSA-N 5-[4-[(dimethylamino)methyl]phenyl]-1-methyl-n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3N(C)C=C(C=3C=C(C=2)C=2C=CC(CN(C)C)=CC=2)C(C)C)=C1CCC GFCCWLHFGVSSSS-UHFFFAOYSA-N 0.000 claims 2
- JMTWKYYDGCAQKL-UHFFFAOYSA-N 5-[4-[(dimethylamino)methyl]phenyl]-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CC=C(CN(C)C)C=C1 JMTWKYYDGCAQKL-UHFFFAOYSA-N 0.000 claims 2
- SZEQILYMUVWQRZ-UHFFFAOYSA-N 5-bromo-1-methyl-n-[(6-methyl-2-oxo-4-propyl-1h-pyridin-3-yl)methyl]-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3N(C)C=C(C=3C=C(Br)C=2)C(C)C)=C1CCC SZEQILYMUVWQRZ-UHFFFAOYSA-N 0.000 claims 2
- KGQNAZYBWOBFAA-UHFFFAOYSA-N 5-bromo-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(Br)C=C2C(C(C)C)=CN(C)C2=C1C(=O)NCC1=C(C)C=C(C)NC1=O KGQNAZYBWOBFAA-UHFFFAOYSA-N 0.000 claims 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 2
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 claims 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- HCGDPEUWCDTZLU-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-(2-methylpyrimidin-5-yl)-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1=CN=C(C)N=C1 HCGDPEUWCDTZLU-UHFFFAOYSA-N 0.000 claims 2
- QIXKJAZCEYTOFN-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-(6-piperazin-1-ylpyridin-3-yl)-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCNCC1 QIXKJAZCEYTOFN-UHFFFAOYSA-N 0.000 claims 2
- JLCORBUPZPSINP-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C(C=N1)=CC=C1N1CCN(C)CC1 JLCORBUPZPSINP-UHFFFAOYSA-N 0.000 claims 2
- WJZFKEKVWFQCTH-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-morpholin-4-yl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1N1CCOCC1 WJZFKEKVWFQCTH-UHFFFAOYSA-N 0.000 claims 2
- IRQOCUDPMHHDSC-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-piperidin-4-yl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1CCNCC1 IRQOCUDPMHHDSC-UHFFFAOYSA-N 0.000 claims 2
- LLKXMWGSDAISGK-UHFFFAOYSA-N n-[(4-ethyl-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-morpholin-4-yl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(C)NC(=O)C(CNC(=O)C=2C=3N(C)C=C(C=3C=C(C=2)N2CCOCC2)C(C)C)=C1CC LLKXMWGSDAISGK-UHFFFAOYSA-N 0.000 claims 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims 2
- 150000003536 tetrazoles Chemical class 0.000 claims 2
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims 2
- 229930192474 thiophene Natural products 0.000 claims 2
- 150000003852 triazoles Chemical class 0.000 claims 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- FOLQBSFOSSTUTR-UHFFFAOYSA-N 5-bromo-1-methyl-n-[(4-methyl-2-oxo-1h-pyridin-3-yl)methyl]-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(Br)C=C2C(C(C)C)=CN(C)C2=C1C(=O)NCC1=C(C)C=CNC1=O FOLQBSFOSSTUTR-UHFFFAOYSA-N 0.000 claims 1
- UZOBNBUIXJLSEB-UHFFFAOYSA-N 5-bromo-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-3-propan-2-yl-1h-indole-7-carboxamide Chemical compound C1=C(Br)C=C2C(C(C)C)=CNC2=C1C(=O)NCC1=C(C)C=C(C)NC1=O UZOBNBUIXJLSEB-UHFFFAOYSA-N 0.000 claims 1
- HPGAZWNSPVVXBD-UHFFFAOYSA-N 5-cyclopropyl-n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C2C(C(C)C)=CN(C)C2=C(C(=O)NCC=2C(NC(C)=CC=2C)=O)C=C1C1CC1 HPGAZWNSPVVXBD-UHFFFAOYSA-N 0.000 claims 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical group C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- CBDQSIAZJUYWHG-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=CC=C2C(C(C)C)=CN(C)C2=C1C(=O)NCC1=C(C)C=C(C)NC1=O CBDQSIAZJUYWHG-UHFFFAOYSA-N 0.000 claims 1
- HCNLUTMVBSQJKX-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-1-methyl-5-methylsulfonyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(S(C)(=O)=O)C=C2C(C(C)C)=CN(C)C2=C1C(=O)NCC1=C(C)C=C(C)NC1=O HCNLUTMVBSQJKX-UHFFFAOYSA-N 0.000 claims 1
- XPBKDGLBCCVAEO-UHFFFAOYSA-N n-[(4,6-dimethyl-2-oxo-1h-pyridin-3-yl)methyl]-5-methoxy-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C=12N(C)C=C(C(C)C)C2=CC(OC)=CC=1C(=O)NCC1=C(C)C=C(C)NC1=O XPBKDGLBCCVAEO-UHFFFAOYSA-N 0.000 claims 1
- YWGJJJSPKYYNIC-UHFFFAOYSA-N n-[(4-benzyl-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-5-bromo-1-methyl-3-propan-2-ylindole-7-carboxamide Chemical compound C1=C(Br)C=C2C(C(C)C)=CN(C)C2=C1C(=O)NCC(C(NC(C)=C1)=O)=C1CC1=CC=CC=C1 YWGJJJSPKYYNIC-UHFFFAOYSA-N 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 0 *c(c1cc(*)c2)c[n](*)c1c2C(NCC1=C(*)C(*)=C(*)NC1=O)=O Chemical compound *c(c1cc(*)c2)c[n](*)c1c2C(NCC1=C(*)C(*)=C(*)NC1=O)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41847010P | 2010-12-01 | 2010-12-01 | |
| US61/418,470 | 2010-12-01 | ||
| PCT/US2011/062537 WO2012075080A1 (en) | 2010-12-01 | 2011-11-30 | Indoles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544840A JP2013544840A (ja) | 2013-12-19 |
| JP2013544840A5 true JP2013544840A5 (enExample) | 2015-01-22 |
| JP5908493B2 JP5908493B2 (ja) | 2016-04-26 |
Family
ID=46172248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013542121A Expired - Fee Related JP5908493B2 (ja) | 2010-12-01 | 2011-11-30 | インドール |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8765792B2 (enExample) |
| EP (1) | EP2646020B1 (enExample) |
| JP (1) | JP5908493B2 (enExample) |
| ES (1) | ES2607064T3 (enExample) |
| WO (1) | WO2012075080A1 (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130102477A1 (en) | 2010-06-23 | 2013-04-25 | Ryan D. Morin | Biomarkers for non-hodgkin lymphomas and uses thereof |
| AU2011298987B2 (en) | 2010-09-10 | 2017-09-28 | Epizyme, Inc. | Inhibitors of human EZH2, and methods of use thereof |
| US9175331B2 (en) | 2010-09-10 | 2015-11-03 | Epizyme, Inc. | Inhibitors of human EZH2, and methods of use thereof |
| EP3323820B1 (en) | 2011-02-28 | 2023-05-10 | Epizyme, Inc. | Substituted 6,5-fused bicyclic heteroaryl compounds |
| TW201733984A (zh) | 2011-04-13 | 2017-10-01 | 雅酶股份有限公司 | 經取代之苯化合物 |
| JO3363B1 (ar) | 2011-04-13 | 2019-03-13 | Epizyme Inc | مركبات بنزين مستبدلة بأريل أو أريل غير متجانس |
| BR112014007603A2 (pt) | 2011-09-30 | 2017-06-13 | Glaxosmithkline Llc | métodos de tratamento do câncer |
| US9206128B2 (en) | 2011-11-18 | 2015-12-08 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| WO2013075084A1 (en) | 2011-11-18 | 2013-05-23 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| CA2862289C (en) | 2012-02-10 | 2019-11-26 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| DK3628670T3 (da) | 2012-04-13 | 2022-12-05 | Epizyme Inc | Saltform til ezh2-hæmning |
| US9562041B2 (en) | 2012-05-16 | 2017-02-07 | Glaxosmithkline Llc | Enhancer of zeste homolog 2 inhibitors |
| KR102021642B1 (ko) * | 2012-10-15 | 2019-09-16 | 에피자임, 인코포레이티드 | 암을 치료하는 방법 |
| CN105102432B (zh) | 2012-10-15 | 2019-01-04 | Epizyme股份有限公司 | 经取代的苯化合物 |
| CA2894216A1 (en) * | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | 1,4-pyridone compounds |
| AU2013361079B2 (en) | 2012-12-21 | 2018-07-26 | Epizyme, Inc. | 1,4-pyridone bicyclic heteroaryl compounds |
| EP2970131B1 (en) | 2013-03-14 | 2017-11-15 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US9447079B2 (en) | 2013-03-14 | 2016-09-20 | Epizyme, Inc. | PRMT1 inhibitors and uses thereof |
| US9120757B2 (en) | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| EP2970181B1 (en) | 2013-03-14 | 2017-06-07 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US9394258B2 (en) | 2013-03-14 | 2016-07-19 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| WO2014153226A1 (en) | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US20160039767A1 (en) | 2013-03-14 | 2016-02-11 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| EP2970136A1 (en) | 2013-03-14 | 2016-01-20 | Epizyme, Inc. | Arginine methyl transferase inhibtors and uses thereof |
| JP2016514164A (ja) | 2013-03-14 | 2016-05-19 | エピザイム，インコーポレイティド | アルギニンメチルトランスフェラーゼ阻害剤としてのピラゾール誘導体およびその使用 |
| US9023883B2 (en) | 2013-03-14 | 2015-05-05 | Epizyme, Inc. | PRMT1 inhibitors and uses thereof |
| WO2014151142A1 (en) | 2013-03-15 | 2014-09-25 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| US9505745B2 (en) | 2013-04-30 | 2016-11-29 | Glaxosmithkline Intellectual Property (No. 2) Limited | Enhancer of zeste homolog 2 inhibitors |
| CN105452246A (zh) * | 2013-06-06 | 2016-03-30 | 葛兰素史密斯克莱知识产权（第2号）有限公司 | Zeste增强子同源物2的抑制剂 |
| EP3019494B1 (en) | 2013-07-10 | 2017-06-21 | Glaxosmithkline Intellectual Property (No. 2) Limited | Enhancer of zeste homolog 2 inhibitors |
| WO2015023915A1 (en) | 2013-08-15 | 2015-02-19 | Constellation Pharmaceuticals, Inc. | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof |
| EP3057962B1 (en) | 2013-10-16 | 2023-10-18 | Epizyme, Inc. | Hydrochloride salt form for ezh2 inhibition |
| US9822103B2 (en) | 2013-11-22 | 2017-11-21 | Bristol-Myers Squibb Company | Inhibitors of lysine methyl transferase |
| WO2015128837A1 (en) | 2014-02-26 | 2015-09-03 | Glaxosmithkline Intellectual Property (No.2) Limited | Methods of treating cancer patients responding to ezh2 inhibitor gsk126 |
| TW201636344A (zh) | 2014-12-05 | 2016-10-16 | 美國禮來大藥廠 | Ｅｚｈ２抑制劑 |
| WO2016102493A1 (en) * | 2014-12-22 | 2016-06-30 | Bayer Pharma Aktiengesellschaft | Imidazopyridine ezh2 inhibitors |
| EP3236962A2 (en) | 2014-12-23 | 2017-11-01 | University of Copenhagen | Treatment of cancer by inhibiting ezh2 activity |
| CN108025191A (zh) | 2015-08-24 | 2018-05-11 | Epizyme股份有限公司 | 治疗癌症的方法 |
| TW201718598A (zh) | 2015-08-27 | 2017-06-01 | 美國禮來大藥廠 | Ｅｚｈ２抑制劑 |
| US10577350B2 (en) | 2015-08-28 | 2020-03-03 | Constellation Pharmaceuticals, Inc. | Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide |
| CN105801463A (zh) * | 2016-03-31 | 2016-07-27 | 常州大学 | 一种2-甲酸-3-丙氧基-5-甲基吡咯的合成方法 |
| CN107573327B (zh) * | 2016-07-05 | 2020-03-31 | 四川大学 | 吲唑-甲酰胺-吡啶酮衍生物及其制备方法和用途 |
| AU2017323112B2 (en) * | 2016-09-07 | 2020-11-26 | Haihe Biopharma Co., Ltd. | Pyrido five-element aromatic ring compound, preparation method therefor and use thereof |
| EP3529242A1 (en) | 2016-10-19 | 2019-08-28 | Constellation Pharmaceuticals, Inc. | Synthesis of inhibitors of ezh2 |
| WO2018086590A1 (zh) * | 2016-11-11 | 2018-05-17 | 上海海雁医药科技有限公司 | 砜基取代的苯并杂环衍生物、其制法与医药上的用途 |
| WO2018137639A1 (zh) * | 2017-01-25 | 2018-08-02 | 恩瑞生物医药科技（上海）有限公司 | 一种组蛋白甲基转移酶ezh2抑制剂、其制备方法及其医药用途 |
| JP2021531340A (ja) | 2018-07-09 | 2021-11-18 | フォンダシヨン、アジール、デ、アブグルスFondation Asile Des Aveugles | 眼障害を治療するためのｐｒｃ２サブユニットの阻害 |
| US11535621B2 (en) * | 2019-07-31 | 2022-12-27 | Ribon Therapeutics, Inc. | Heterobicyclic amides as inhibitors of CD38 |
| CN113666920B (zh) * | 2020-04-14 | 2025-10-03 | 浙江华海药业股份有限公司 | 苯并恶唑类化合物制备方法及其在医药领域的应用 |
| WO2022146698A1 (en) * | 2020-12-29 | 2022-07-07 | Revolution Medicines, Inc. | Sos1 inhibitors and uses thereof |
| TW202241418A (zh) | 2021-01-29 | 2022-11-01 | 美商律幫治療股份有限公司 | 作為cd38之抑制劑的喹啉及氮雜喹啉 |
| US20240350508A1 (en) | 2021-08-25 | 2024-10-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of ezh2 inhibitors for the treatment of aortic valve stenosis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5330986A (en) * | 1992-11-24 | 1994-07-19 | Hoechst-Roussel Pharmaceuticals Inc. | Indole-7-carboxamide derivatives |
| DE10022925A1 (de) | 2000-05-11 | 2001-11-15 | Basf Ag | Substituierte Indole als PARP-Inhibitoren |
| GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
| WO2009006577A2 (en) * | 2007-07-03 | 2009-01-08 | The Regents Of The University Of Michigan | Compositions and methods for inhibiting ezh2 |
| CN104557914A (zh) * | 2008-09-26 | 2015-04-29 | 新加坡科技研究局 | 3-脱氮瓶菌素衍生物 |
| WO2011140325A1 (en) * | 2010-05-07 | 2011-11-10 | Glaxosmithkline Llc | Indazoles |
| ES2528269T3 (es) | 2010-05-07 | 2015-02-06 | Glaxosmithkline Llc | Azaindazoles |
| US8536179B2 (en) * | 2010-05-07 | 2013-09-17 | Glaxosmithkline Llc | Indoles |
| EP3323820B1 (en) | 2011-02-28 | 2023-05-10 | Epizyme, Inc. | Substituted 6,5-fused bicyclic heteroaryl compounds |
-
2011
- 2011-11-30 US US13/990,505 patent/US8765792B2/en not_active Expired - Fee Related
- 2011-11-30 WO PCT/US2011/062537 patent/WO2012075080A1/en not_active Ceased
- 2011-11-30 JP JP2013542121A patent/JP5908493B2/ja not_active Expired - Fee Related
- 2011-11-30 ES ES11844228.4T patent/ES2607064T3/es active Active
- 2011-11-30 EP EP11844228.4A patent/EP2646020B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013528591A5 (enExample) | ||
| JP2013527173A5 (enExample) | ||
| HRP20210094T1 (hr) | POSTUPAK PRIPRAVE DERIVATIVA OKSAZOLO[4,5-b]PIRIDINA I TIAZOLO[4,5-b]PIRIDINA KAO INHIBITORA IRAK4 NAMIJENJENIH LIJEČENJU RAKA | |
| ES2642586T3 (es) | Compuestos heterocíclicos condensados como moduladores de canales iónicos | |
| AU2003252011B8 (en) | Substituted 2-alkylamine nicotinic amide derivatives and use there of | |
| CN100506801C (zh) | 糖元合成酶激酶3的抑制剂 | |
| AU2009224329B2 (en) | Pyridylaminoacetic acid compound | |
| JP2015501784A5 (enExample) | ||
| JP2013525498A5 (enExample) | ||
| AU2018201953A1 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
| JP2013501720A5 (enExample) | ||
| AU2011272198A1 (en) | Novel nicotinamide derivatives or salts thereof | |
| JP2013517264A5 (enExample) | ||
| JP2018118992A5 (enExample) | ||
| CA2738929A1 (en) | Heteroaryl substituted indole compounds useful as mmp-13 inhibitors | |
| SK8582003A3 (en) | Substituted alkylamine derivatives and methods of use | |
| RU2004112191A (ru) | Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха | |
| CA2798622A1 (en) | Indoles | |
| ES2530449T3 (es) | Inhibidores de Syk de imidazopiridinas | |
| JP2016523911A5 (enExample) | ||
| EP2073811A2 (en) | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases | |
| AU2007271964A1 (en) | Pyrimidine derivatives as ALK-5 inhibitors | |
| JP2008056659A (ja) | 酸分泌抑制薬 | |
| HRP20220096T1 (hr) | Inhibitori lizin specifične demetilaze-1 | |
| ME02416B (me) | Trpv4 antagonisтi |